1. Frontline treatment approaches in TP53-aberrant mantle cell lymphoma. Issue 1 (2nd January 2023) Authors: Shah, Nikesh N.; Castillo-Tokumori, Franco; Whiting, Junmin; Boulware, David; Sandoval-Sus, Jose; Knepper, Todd C.; Hussaini, Mohammad; Tao, Jianguo; Chavez, Julio C.; Isenalumhe, Leidy; Gaballa, Sameh; Saeed, Hayder; Bello, Celeste; Sokol, Lubomir; Pinilla-Ibarz, Javier; Shah, Bijal D. Journal: Leukemia & lymphoma Issue: Volume 64:Issue 1(2023) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HER2-positive metastatic breast cancer: a double-edged sword. (September 2012) Authors: Sandoval-Sus, Jose; Mahtani, Reshma; Glück, Stefan Journal: Breast cancer management Issue: Volume 1:Number 3(2012) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: The future is now. (May 2017) Authors: Juárez-Salcedo, Luis Miguel; Sandoval-Sus, Jose; Sokol, Lubomir; Chavez, Julio C.; Dalia, Samir Journal: Critical reviews in oncology/hematology Issue: Volume 113(2017) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma. (May 2021) Authors: Sandoval-Sus, Jose; Chavez, Julio C. Journal: Therapeutic advances in hematology Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Vertebral osteomyelitis caused by Mycobacterium abscessus. (7th August 2013) Authors: Garcia, Daniel C; Sandoval-Sus, Jose; Razzaq, Kanwal; Young, Lary Journal: BMJ case reports Issue: Volume 2013 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗